Mega Lifesciences Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 11, 2023 at 11:21 am
Share
Mega Lifesciences Public Company Limited reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was THB 3,978.03 million compared to THB 1,662.63 million a year ago. Net income was THB 530.95 million compared to THB 569.51 million a year ago. Basic earnings per share from continuing operations was THB 0.61 compared to THB 0.65 a year ago.
For the six months, revenue was THB 7,757.22 million compared to THB 7,798.75 million a year ago. Net income was THB 983.94 million compared to THB 1,183.51 million a year ago. Basic earnings per share from continuing operations was THB 1.13 compared to THB 1.36 a year ago.
Mega Lifesciences Public Company Limited is a Thailand-based company. The Company is engaged in manufacturing and selling through independent distributors of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins and fast-moving consumer goods, as well as the provision of distribution services relating to such products. Its segments include Brands, Distribution, and OEM (Original Equipment Manufacturer). The Brands segment represents a business segment in which goods are manufactured and sold under brands owned by the Company. The Distribution segment represents a service business segment in which the Company provides logistical and marketing services for goods trading purposes and the sale of goods manufactured by third parties. The OEM segment represents a business segment in which goods are manufactured by third parties under brands not owned by the Company.